Our report clarifies the role of ATP6V1B2 in patients with deafness and onycho-osteodystrophy and confirms that a recurring ATP6V1B2 c.1516C>T [p.(Arg506*)], variant causes dominant deafness-onychodystrophy (DDOD) syndrome.
Keywords: ATP6V1B2; Zimmermann–Laband syndrome; deafness–onychodystrophy–osteodystrophy–mental retardation–seizures; dominant deafness–onychodystrophy; whole‐exome sequencing.